Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 29.75% vs 12.53% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 4.10% vs 9.55% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 9.19% vs -2.53% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -1.78% vs -38.55% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Aristo Bio-Tech With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
318.09
141.54
176.55
124.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
318.09
141.54
176.55
124.74%
Raw Material Cost
295.60
129.80
165.80
127.73%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.07
-3.40
3.33
97.94%
Employee Cost
4.10
1.16
2.94
253.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
9.19
3.05
6.14
201.31%
Total Expenditure (Excl Depreciation)
308.82
130.62
178.20
136.43%
Operating Profit (PBDIT) excl Other Income
9.27
10.92
-1.65
-15.11%
Other Income
0.45
1.51
-1.06
-70.20%
Operating Profit (PBDIT)
9.72
12.43
-2.71
-21.80%
Interest
1.66
2.62
-0.96
-36.64%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8.06
9.81
-1.75
-17.84%
Depreciation
2.60
2.20
0.40
18.18%
Profit Before Tax
5.47
7.61
-2.14
-28.12%
Tax
1.40
1.87
-0.47
-25.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.06
5.73
-1.67
-29.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.06
5.73
-1.67
-29.14%
Equity Capital
6.81
24.95
-18.14
-72.71%
Face Value
10.00
10.00
0.00
Reserves
30.52
46.64
-16.12
-34.56%
Earnings per share (EPS)
5.96
2.30
3.66
159.13%
Diluted Earnings per share
5.97
2.30
3.67
159.57%
Operating Profit Margin (Excl OI)
2.91%
7.72%
0.00
-4.81%
Gross Profit Margin
2.53%
6.93%
0.00
-4.40%
PAT Margin
1.28%
4.05%
0.00
-2.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 318.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.75% vs 12.53% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 4.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.10% vs 9.55% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.19% vs -2.53% in Mar 2024
Annual - Interest
Interest 1.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.78% vs -38.55% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.91%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Footer loading
